Characterization of a Novel Isoform of Caspase-9 That Inhibits Apoptosis

James M Angelastro, Nah Yong Moon, David X. Liu, An Suei Yang, Lloyd A. Greene, Thomas F. Franke

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

We have identified a novel isoform of rat caspase-9 in which the C terminus of full-length caspase-9 is replaced with an alternative peptide sequence. Casp-9-CTD (where CTD is carboxyl-terminal divergent) is expressed in multiple tissues, with the relative highest expression observed in ovary and heart. Casp-9-CTD was found primarily in the cytoplasm and was not detected in the nucleus. Structural predictions suggest that in contrast to full-length caspase-9, casp-9-CTD will not be processed. Our model is supported by reduced protease activity of casp-9-CTD preparations in vitro and by the lack of detectable processing of casp-9-CTD proenzyme or the induction of cell death following transfection into cells. Both neuronal and non-neuronal cell types transfected with casp-9-CTD were resistant to death evoked by trophic factor deprivation or DNA damage. In addition, cytosolic lysates prepared from cells permanently expressing exogenous casp-9-CTD were resistant to caspase induction by cytochrome c in reconstitution assays. Taken together, our observations indicate that casp-9-CTD acts as a dominant-negative variant. Its expression in various tissues indicates a physiological role in regulating cell death.

Original languageEnglish (US)
Pages (from-to)12190-12200
Number of pages11
JournalJournal of Biological Chemistry
Volume276
Issue number15
DOIs
StatePublished - Apr 13 2001
Externally publishedYes

Fingerprint

Caspase 9
Protein Isoforms
Cell death
Apoptosis
Cell Death
Tissue
Enzyme Precursors
Caspases
Cytochromes c
DNA Damage
Transfection
Rats
Ovary
Assays
Cytoplasm
Peptide Hydrolases
Peptides
DNA
Processing

ASJC Scopus subject areas

  • Biochemistry

Cite this

Characterization of a Novel Isoform of Caspase-9 That Inhibits Apoptosis. / Angelastro, James M; Moon, Nah Yong; Liu, David X.; Yang, An Suei; Greene, Lloyd A.; Franke, Thomas F.

In: Journal of Biological Chemistry, Vol. 276, No. 15, 13.04.2001, p. 12190-12200.

Research output: Contribution to journalArticle

Angelastro, James M ; Moon, Nah Yong ; Liu, David X. ; Yang, An Suei ; Greene, Lloyd A. ; Franke, Thomas F. / Characterization of a Novel Isoform of Caspase-9 That Inhibits Apoptosis. In: Journal of Biological Chemistry. 2001 ; Vol. 276, No. 15. pp. 12190-12200.
@article{10e6cddba2064dd68e32debecaa2ecc0,
title = "Characterization of a Novel Isoform of Caspase-9 That Inhibits Apoptosis",
abstract = "We have identified a novel isoform of rat caspase-9 in which the C terminus of full-length caspase-9 is replaced with an alternative peptide sequence. Casp-9-CTD (where CTD is carboxyl-terminal divergent) is expressed in multiple tissues, with the relative highest expression observed in ovary and heart. Casp-9-CTD was found primarily in the cytoplasm and was not detected in the nucleus. Structural predictions suggest that in contrast to full-length caspase-9, casp-9-CTD will not be processed. Our model is supported by reduced protease activity of casp-9-CTD preparations in vitro and by the lack of detectable processing of casp-9-CTD proenzyme or the induction of cell death following transfection into cells. Both neuronal and non-neuronal cell types transfected with casp-9-CTD were resistant to death evoked by trophic factor deprivation or DNA damage. In addition, cytosolic lysates prepared from cells permanently expressing exogenous casp-9-CTD were resistant to caspase induction by cytochrome c in reconstitution assays. Taken together, our observations indicate that casp-9-CTD acts as a dominant-negative variant. Its expression in various tissues indicates a physiological role in regulating cell death.",
author = "Angelastro, {James M} and Moon, {Nah Yong} and Liu, {David X.} and Yang, {An Suei} and Greene, {Lloyd A.} and Franke, {Thomas F.}",
year = "2001",
month = "4",
day = "13",
doi = "10.1074/jbc.M009523200",
language = "English (US)",
volume = "276",
pages = "12190--12200",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "15",

}

TY - JOUR

T1 - Characterization of a Novel Isoform of Caspase-9 That Inhibits Apoptosis

AU - Angelastro, James M

AU - Moon, Nah Yong

AU - Liu, David X.

AU - Yang, An Suei

AU - Greene, Lloyd A.

AU - Franke, Thomas F.

PY - 2001/4/13

Y1 - 2001/4/13

N2 - We have identified a novel isoform of rat caspase-9 in which the C terminus of full-length caspase-9 is replaced with an alternative peptide sequence. Casp-9-CTD (where CTD is carboxyl-terminal divergent) is expressed in multiple tissues, with the relative highest expression observed in ovary and heart. Casp-9-CTD was found primarily in the cytoplasm and was not detected in the nucleus. Structural predictions suggest that in contrast to full-length caspase-9, casp-9-CTD will not be processed. Our model is supported by reduced protease activity of casp-9-CTD preparations in vitro and by the lack of detectable processing of casp-9-CTD proenzyme or the induction of cell death following transfection into cells. Both neuronal and non-neuronal cell types transfected with casp-9-CTD were resistant to death evoked by trophic factor deprivation or DNA damage. In addition, cytosolic lysates prepared from cells permanently expressing exogenous casp-9-CTD were resistant to caspase induction by cytochrome c in reconstitution assays. Taken together, our observations indicate that casp-9-CTD acts as a dominant-negative variant. Its expression in various tissues indicates a physiological role in regulating cell death.

AB - We have identified a novel isoform of rat caspase-9 in which the C terminus of full-length caspase-9 is replaced with an alternative peptide sequence. Casp-9-CTD (where CTD is carboxyl-terminal divergent) is expressed in multiple tissues, with the relative highest expression observed in ovary and heart. Casp-9-CTD was found primarily in the cytoplasm and was not detected in the nucleus. Structural predictions suggest that in contrast to full-length caspase-9, casp-9-CTD will not be processed. Our model is supported by reduced protease activity of casp-9-CTD preparations in vitro and by the lack of detectable processing of casp-9-CTD proenzyme or the induction of cell death following transfection into cells. Both neuronal and non-neuronal cell types transfected with casp-9-CTD were resistant to death evoked by trophic factor deprivation or DNA damage. In addition, cytosolic lysates prepared from cells permanently expressing exogenous casp-9-CTD were resistant to caspase induction by cytochrome c in reconstitution assays. Taken together, our observations indicate that casp-9-CTD acts as a dominant-negative variant. Its expression in various tissues indicates a physiological role in regulating cell death.

UR - http://www.scopus.com/inward/record.url?scp=0035853709&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035853709&partnerID=8YFLogxK

U2 - 10.1074/jbc.M009523200

DO - 10.1074/jbc.M009523200

M3 - Article

C2 - 11278518

AN - SCOPUS:0035853709

VL - 276

SP - 12190

EP - 12200

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 15

ER -